language Türkçe
Article 2023 · 9 citations

Myokine musclin alleviates lipid accumulation in 3T3-L1 adipocytes through PKA/p38-mediated upregulation of lipolysis and suppression of lipogenesis

Choi, Sung Woo, Oh, Heeseung, Park, Seung Yeon, Cho, Wonjun, Abd El-Aty, A. M., Hacimuftuoglu, Ahmet, Jeong, Ji Hoon, Jung, Tae Woo

Abstract

Musclin (MUS), an exercise-responsive myokine, has been documented to attenuate inflammation and enhance physical endurance. However, the effects of MUS on differentiation and related molecular mechanisms in adipocytes have not yet been studied. In this study, we found that treatment with MUS attenuated lipid accumulation in fully differentiated 3T3-L1 cells. Furthermore, MUS treatment enhanced lipolysis assessed by glycerol release, and caused apoptosis, whereas it reduced the expression of lipo-genic proteins, such as PPARg and processed SREBP1. Treatment with MUS augmented phosphorylated PKA expression, whereas suppressed p38 phosphorylation in 3T3-L1 adipocytes. H89, a selective PKA inhibitor reduced the effects of MUS on lipogenic lipid accumulation as well as lipolysis except for apoptosis. These results suggest that MUS promotes lipolysis and suppresses lipogenesis through a PKA/ p38-dependent pathway, thereby ameliorating lipid deposition in cultured adipocytes. The current study offers the potential of MUS as a therapeutic approach for treating obesity with few side effects.(c) 2022 Elsevier Inc. All rights reserved.

Keywords
Musclin Myokine Adipocyte Obesity Lipogenesis Lipolysis SKELETAL-MUSCLE PROTEIN DIFFERENTIATION RESISTANCE OSTEOCRIN EXERTS FAT
WoS Categories
Biochemistry & Molecular Biology Biophysics
Sustainable Development Goals
Citation
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Year
2023
Volume
642
Pages
113-117
ISSN
0006-291X
eISSN
1090-2104
DOI
10.1016/j.bbrc.2022.12.056
WoS UID
WOS:000912303100001
Open via DOI